Every report comes from a Lived member, sent anonymously.
Have you had Lung transplant for COPD?
A lung transplant is surgery that replaces one or both diseased lungs with healthy lungs from a donor, almost always a person who has died. It is considered for people with severe lung disease that is likely to shorten life and no longer responds to medicines, oxygen, pulmonary rehabilitation or other treatments. The most common reasons are COPD (chronic obstructive pulmonary disease, including emphysema), pulmonary fibrosis and other scarring lung diseases, cystic fibrosis, alpha-1 antitrypsin deficiency and pulmonary hypertension (high blood pressure in the lung arteries). A double (bilateral) transplant replaces both lungs; a single lung transplant replaces only the worse one. Which is offered depends on the disease, the person's overall health and which donor lungs become available. When the heart is also failing, a combined heart-lung transplant is occasionally done. A transplant does not cure the underlying situation so much as exchange it for a different one: a new lung that can restore much more breathing capacity, in return for lifelong anti-rejection medicines, frequent monitoring and new risks. Because donor lungs are scarce, transplant teams select candidates carefully. People may not be offered a transplant if they still smoke or use other substances, have had cancer recently, have serious disease of other organs such as the kidneys or heart, are too frail or malnourished to recover, or cannot reliably take medicines and keep appointments. Some centers also limit age. Specialists recommend referral to a transplant center well before the need becomes urgent, because early evaluation leaves time to work on weight, fitness and other barriers.
Evaluation at a transplant center takes several visits and tests: detailed lung function testing and imaging, heart tests such as an echocardiogram (an ultrasound of the heart) and sometimes a cardiac catheterization, blood and tissue typing, bone density testing and age-appropriate cancer screening. A social worker and a psychologist also assess support at home and readiness for the demands of recovery. Most centers require a committed caregiver who can stay with the recipient for the first months. Candidates must stop all tobacco and nicotine products, including vaping and nicotine replacement, and inhaled cannabis, and centers check this with blood or urine tests. Vaccines are updated early, because some live vaccines cannot be given after transplant and others work less well once the immune system is suppressed. Pulmonary rehabilitation (supervised exercise and breathing training) continues while waiting, since strength going in affects recovery coming out. In the United States, a person accepted for transplant receives a lung composite allocation score that reflects how urgently they need a lung and how likely they are to benefit, and it is updated as their condition changes. Waiting times vary widely and are hard to predict. Donor lungs must be used within hours, so people on the list keep their phone charged, have a bag packed, arrange transportation and stay within reach of the center. When the call comes, the team will say to stop eating and drinking and which medicines to bring.
Lung transplant is done under general anesthesia, so the person is fully asleep. For a single lung, the surgeon opens the chest on that side; for a double transplant, the incision usually runs beneath the breasts across both sides of the chest. The diseased lung is removed, and the donor lung's airway and blood vessels are stitched to the recipient's. In a double transplant, the two sides are usually done one after the other. Some operations need a heart-lung bypass machine or ECMO (extracorporeal membrane oxygenation, a machine that adds oxygen to the blood outside the body) to support circulation and breathing during surgery. A single lung transplant typically takes about 4 to 8 hours and a double transplant about 6 to 12 hours. Chest tubes are placed at the end to drain air, blood and fluid while the new lungs expand.
Recovery begins in the intensive care unit, usually with a breathing machine (ventilator) until the new lungs can work on their own. Chest tubes, IV lines and close monitoring are routine in the first days. Anti-rejection medicines start right away. Physical therapy and walking begin early, and the hospital stay is often one to three weeks, longer if complications arise. The first months are intense. Many centers ask recipients to live within easy reach of the hospital for about three months, attending frequent clinic visits, blood tests, chest X-rays, bronchoscopies (a camera passed into the airways to check the new lung and take samples) and daily pulmonary rehabilitation. Driving usually waits several weeks while the chest heals, and full recovery takes about six months. Most people find they can breathe and do far more than before the transplant. Anti-rejection medicines are taken for life, typically a combination such as tacrolimus, mycophenolate and prednisone (a steroid), with doses adjusted by blood levels. Taking every dose on time is essential, as is checking with the transplant team before starting any new medicine or supplement, since many interact. Because rejection often causes no symptoms at first, most recipients measure their lung function at home every day with a small handheld spirometer. Avoiding smoke, polluted air and sick contacts, keeping vaccines current and regular cancer screening become part of daily life. Call the transplant team right away if home spirometry falls by the amount the team specifies (often about 10 percent from the previous reading), or for new or worsening shortness of breath, cough, rising oxygen needs, fever or unusual tiredness. These can signal rejection or infection, which look alike at first and need different treatment.
Lung transplant carries more risk than most other organ transplants. The highest risk is in the first year. About four in five recipients are alive one year after transplant, about three in five at five years and about two in five at ten years, with wide differences by underlying disease, age and overall health. Early complications include primary graft dysfunction, in which the new lung is injured during removal from the donor or implantation and does not work well at first; bleeding; blood clots; and problems where the airway or blood vessels were joined. Acute rejection, when the immune system attacks the new lung, is most common in the first months but can happen later; it is usually treated with stronger anti-rejection medicines. The main long-term threat is chronic rejection, called chronic lung allograft dysfunction (CLAD), which over the years affects more than half of recipients. Its most common form, bronchiolitis obliterans syndrome, slowly scars the small airways and shows up as a steady drop in lung function, often before shortness of breath, cough or fatigue appear. Treatment aims to slow it, for example with changes to anti-rejection medicines or long-term azithromycin (an antibiotic with anti-inflammatory effects), but lost function often does not return. Some people stay stable for years, while others decline, and a second transplant is considered for a few. Treating acid reflux and infections promptly and avoiding smoke may lower the risk. Lifelong immunosuppression brings its own trade-offs: serious infections, kidney damage, diabetes, high blood pressure, bone thinning and a higher risk of some cancers. By five years, at least one in five recipients has developed cancer or heart problems.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with Lung transplant, what to expect, or ask the community a question.